Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 87



Drasar B.

Int Health. 2009 Sep;1(1):1-2. doi: 10.1016/j.inhe.2009.06.001. No abstract available.


Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis.

Suthar AB, Lawn SD, del Amo J, Getahun H, Dye C, Sculier D, Sterling TR, Chaisson RE, Williams BG, Harries AD, Granich RM.

PLoS Med. 2012;9(7):e1001270. doi: 10.1371/journal.pmed.1001270. Epub 2012 Jul 24. Review.


Feasibility, yield, and cost of active tuberculosis case finding linked to a mobile HIV service in Cape Town, South Africa: a cross-sectional study.

Kranzer K, Lawn SD, Meyer-Rath G, Vassall A, Raditlhalo E, Govindasamy D, van Schaik N, Wood R, Bekker LG.

PLoS Med. 2012;9(8):e1001281. doi: 10.1371/journal.pmed.1001281. Epub 2012 Aug 7.


Diagnosis of extrapulmonary tuberculosis using the Xpert(®) MTB/RIF assay.

Lawn SD, Zumla AI.

Expert Rev Anti Infect Ther. 2012 Jun;10(6):631-5. doi: 10.1586/eri.12.43.


HIV-positive patients treated for multidrug-resistant tuberculosis: clinical outcomes in the HAART era.

Palacios E, Franke M, Muñoz M, Hurtado R, Dallman R, Chalco K, Guerra D, Mestanza L, Llaro K, Bonilla C, Sebastian J, Bayona J, Lygizos M, Anger H, Shin S.

Int J Tuberc Lung Dis. 2012;16(3):348-54. doi: 10.5588/ijtld.11.0473. Erratum in: Int J Tuberc Lung Dis. 2012 Apr;16(4):568. Lyzigos, M [corrected to Lygizos, M].


Location of Xpert® MTB/RIF in centralised laboratories in South Africa undermines potential impact.

Lawn SD, Kerkhoff AD, Wood R.

Int J Tuberc Lung Dis. 2012 May;16(5):701; author reply 702. doi: 10.5588/ijtld.12.0131. No abstract available.


Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community.

Gupta A, Wood R, Kaplan R, Bekker LG, Lawn SD.

PLoS One. 2012;7(3):e34156. doi: 10.1371/journal.pone.0034156. Epub 2012 Mar 30.


Prevention, diagnosis, and treatment of tuberculosis in children and mothers: evidence for action for maternal, neonatal, and child health services.

Getahun H, Sculier D, Sismanidis C, Grzemska M, Raviglione M.

J Infect Dis. 2012 May 15;205 Suppl 2:S216-27. doi: 10.1093/infdis/jis009. Epub 2012 Mar 22. Review.


Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysis.

Suthar AB, Granich R, Mermin J, Van Rie A.

Bull World Health Organ. 2012 Feb 1;90(2):128C-138C. doi: 10.2471/BLT.11.093260. Epub 2011 Oct 24. Review.


Timing of antiretroviral therapy for HIV-1-associated tuberculosis.

Lawn SD, Wood R.

N Engl J Med. 2012 Feb 2;366(5):474; author reply 475-6. doi: 10.1056/NEJMc1113986#SA1. No abstract available.


Risk factors for mortality in smear-negative tuberculosis suspects: a cohort study in Harare, Zimbabwe.

Macpherson P, Dimairo M, Bandason T, Zezai A, Munyati SS, Butterworth AE, Mungofa S, Rusakaniko S, Fielding K, Mason PR, Corbett EL.

Int J Tuberc Lung Dis. 2011 Oct;15(10):1390-6. doi: 10.5588/ijtld.11.0056.


Progression of subclinical culture-positive tuberculosis to symptomatic disease in HIV-infected individuals.

Lawn SD, Kerkhoff AD, Wood R.

AIDS. 2011 Nov 13;25(17):2190-1. doi: 10.1097/QAD.0b013e32834cda4e. No abstract available.


Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study.

Lawn SD, Kerkhoff AD, Vogt M, Wood R.

Lancet Infect Dis. 2012 Mar;12(3):201-9. doi: 10.1016/S1473-3099(11)70251-1. Epub 2011 Oct 17.


Integration of antiretroviral therapy with tuberculosis treatment.

Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray AL, Gengiah T, Gengiah S, Naidoo A, Jithoo N, Nair G, El-Sadr WM, Friedland G, Abdool Karim Q.

N Engl J Med. 2011 Oct 20;365(16):1492-501. doi: 10.1056/NEJMoa1014181.


Timing of antiretroviral therapy for HIV-1 infection and tuberculosis.

Havlir DV, Kendall MA, Ive P, Kumwenda J, Swindells S, Qasba SS, Luetkemeyer AF, Hogg E, Rooney JF, Wu X, Hosseinipour MC, Lalloo U, Veloso VG, Some FF, Kumarasamy N, Padayatchi N, Santos BR, Reid S, Hakim J, Mohapi L, Mugyenyi P, Sanchez J, Lama JR, Pape JW, Sanchez A, Asmelash A, Moko E, Sawe F, Andersen J, Sanne I; AIDS Clinical Trials Group Study A5221.

N Engl J Med. 2011 Oct 20;365(16):1482-91. doi: 10.1056/NEJMoa1013607.


Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis.

Blanc FX, Sok T, Laureillard D, Borand L, Rekacewicz C, Nerrienet E, Madec Y, Marcy O, Chan S, Prak N, Kim C, Lak KK, Hak C, Dim B, Sin CI, Sun S, Guillard B, Sar B, Vong S, Fernandez M, Fox L, Delfraissy JF, Goldfeld AE; CAMELIA (ANRS 1295–CIPRA KH001) Study Team.

N Engl J Med. 2011 Oct 20;365(16):1471-81. doi: 10.1056/NEJMoa1013911.


Antiretroviral therapy in prevention of HIV and TB: update on current research efforts.

Granich R, Gupta S, Suthar AB, Smyth C, Hoos D, Vitoria M, Simao M, Hankins C, Schwartlander B, Ridzon R, Bazin B, Williams B, Lo YR, McClure C, Montaner J, Hirnschall G; ART in Prevention of HIV and TB Research Writing Group.

Curr HIV Res. 2011 Sep;9(6):446-69. Review.


Tuberculosis in antiretroviral treatment services in resource-limited settings: addressing the challenges of screening and diagnosis.

Lawn SD, Wood R.

J Infect Dis. 2011 Nov 15;204 Suppl 4:S1159-67. doi: 10.1093/infdis/jir411. Review.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk